Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 82-0624479 · Snapshot of IRS recognition, filing currency, financial health, and governance.
FY2023 filed as a Form 990-N placeholder. The IRS has not yet released this organization’s full Form 990 for FY2023. All data on this profile reflects the most recent substantive 990 filing; the placeholder year appears in the Financials tab with no breakdown.
To improve the care of patients with Bladder Cancer with Research and education that is exemplified through participation in promising industry-sponsored clinical trials of new treatments, development of new treatment modalities and improved diagnostic tests, physician and patient education, and Research training.
Total Revenue
$76K
FY2020
Total Expenses
$34K
FY2020
Net Assets
$71K
Program Ratio
91.1%
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.